Furthermore, TCGA data showed that EpCAM overexpression was not closely correlated with age, pT stage, lymph node metastasis, number of lymph node, prostate-specific antigen level, Gleason score, biochemical recurrence, and overall survival. The gene discussed is EPCAM; the disease is metastatic malignant neoplasm in the lymph nodes.